Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Chlamydia pneumoniae and atherosclerosis.

Belland RJ, Ouellette SP, Gieffers J, Byrne GI.

Cell Microbiol. 2004 Feb;6(2):117-27. Review.

PMID:
14706098
2.

Chlamydia pneumoniae and vascular disease: an update.

Mussa FF, Chai H, Wang X, Yao Q, Lumsden AB, Chen C.

J Vasc Surg. 2006 Jun;43(6):1301-7. Review.

3.

Chlamydia pneumoniae and atherosclerosis.

Campbell LA, Kuo CC.

Semin Respir Infect. 2003 Mar;18(1):48-54. Review.

PMID:
12652454
4.

[The relationship between Chlamydia pneumoniae and atherosclerosis].

Gayet A, Baril L, Orfila J.

Presse Med. 2001 Dec 1;30(36):1792-801. Review. French.

PMID:
11771205
5.

Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?

Campbell LA, Kuo CC.

Nat Rev Microbiol. 2004 Jan;2(1):23-32. Review.

PMID:
15035006
6.

Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.

Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, Del Piano M, Cipriani P.

Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):9-14. Review.

PMID:
19309547
7.

Chlamydia pneumoniae and atherosclerosis.

Hoymans VY, Bosmans JM, Ieven M, Vrints CJ.

Acta Chir Belg. 2002 Oct;102(5):317-22. Review.

PMID:
12471763
8.

Chlamydia pneumoniae and atherosclerosis.

Rutherford JD.

Curr Atheroscler Rep. 2000 May;2(3):218-25. Review.

PMID:
11122747
9.

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

Aalto-Setälä K, Laitinen K, Erkkilä L, Leinonen M, Jauhiainen M, Ehnholm C, Tamminen M, Puolakkainen M, Penttilä I, Saikku P.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):578-84.

10.
12.

Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.

Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ.

J Infect Dis. 2001 Jan 15;183(2):232-238.

13.

Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.

Bobryshev YV, Orekhov AN, Killingsworth MC, Lu J.

J Innate Immun. 2011;3(5):483-94. doi: 10.1159/000327522.

PMID:
21625070
14.

Chlamydia pneumoniae and atherosclerosis.

Ouchi K.

Jpn J Infect Dis. 1999 Dec;52(6):223-7. Review.

PMID:
10738358
15.

Chlamydia pneumoniae and atherosclerosis.

Wong YK, Gallagher PJ, Ward ME.

Heart. 1999 Mar;81(3):232-8. Review.

16.

In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells.

Quinn TC, Gaydos CA.

Am Heart J. 1999 Nov;138(5 Pt 2):S507-11.

PMID:
10539860
17.

Infection with Chlamydia pneumoniae and atherosclerosis: a review.

Movahed MR.

J S C Med Assoc. 1999 Aug;95(8):303-8. Review.

PMID:
10478518
18.

[Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications].

Nagornev VA, Mal'tseva SV, Seliverstova VG, Sokurenko GIu, Voskan'iants AN.

Arkh Patol. 2004 Mar-Apr;66(2):52-60. Russian.

PMID:
15154386
19.

Value of animal models for Chlamydia pneumoniae-related atherosclerosis.

Fong IW.

Am Heart J. 1999 Nov;138(5 Pt 2):S512-3.

PMID:
10539861
20.

Chlamydia pneumoniae and atherosclerosis: links to the disease process.

Byrne GI, Kalayoglu MV.

Am Heart J. 1999 Nov;138(5 Pt 2):S488-90.

PMID:
10539855
Items per page

Supplemental Content

Support Center